Evaluation of killing, superoxide anion and nitric oxide production by Leishmania infantum-infected dog monocytes.
Protozoa of the genus Leishmania infect reticuloendothelial cells of several mammalian species, including dogs, in which they often give rise to a chronic, not self-healing visceral disease. The parasitocidal mechanism of peripheral blood monocytes towards Leishmania in the dog has not been investigated in detail. Consequently, Leishmania infantum-infected monocyte cultures of healthy dogs were evaluated using the following parameters: (1) phagocytosis and killing capacities; (2) oxidative burst, in terms of superoxide anion (O2-) release, and (3) nitric oxide (NO) activity, in terms of nitrite (NO2-) production in the presence or absence of the NO synthase inhibitor NG-monomethyl-L-arginine (NGMMLA). Parallel experiments were performed on monocytes stimulated with supernatants of concanavalin A-activated PBMC and on unstimulated monocytes. The amount of IFN-gamma in PBMC supernatants used for monocyte activation was determined by a biological assay on a canine Madin Darby cell line. Results demonstrated that phagocytosis, killing capacity and O2- production significantly increased in monocytes stimulated with supernatants, in comparison with unstimulated cells. A positive correlation was observed between the killing capacity, the O2- production and the amount of IFN-gamma in PBMC supernatants employed for monocyte activation. No significant differences were observed in NO production between unstimulated and stimulated cultures, or between the same cultures with and without NGMMLA. Finally, the killing percentage was similar in the presence or absence of NGMMLA, suggesting that in this experimental model peripheral blood dog monocytes lack NO-mediated killing.
Panaro
M A
MA
Istituto di Anatomia Umana Normale, Università di Bari, Italy.
Lisi
S
S
Mitolo
V
V
Acquafredda
A
A
Fasanella
A
A
Carelli
M G
MG
Brandonisio
O
O
D000818:Animals; D003208:Concanavalin A; D004283:Dog Diseases / Q000378:metabolism / Q000469:parasitology; D004285:Dogs; D007371:Interferon-gamma / Q000032:analysis; D018314:Leishmania infantum / Q000276:immunology* / Q000378:metabolism; D007898:Leishmaniasis, Visceral / Q000276:immunology / Q000378:metabolism*; D009000:Monocytes / Q000737:chemistry / Q000378:metabolism* / Q000469:parasitology*; D009569:Nitric Oxide / Q000096:biosynthesis*; D010587:Phagocytosis / Q000276:immunology; D016897:Respiratory Burst / Q000276:immunology; D013481:Superoxides / Q000378:metabolism*
D003208:Concanavalin A; D013481:Superoxides; D009569:Nitric Oxide; D007371:Interferon-gamma